Urinary tract infection in pregnant population, which empirical antimicrobial agent should be specified in each of the three trimesters?

Ginekologia Polska

Volumn 85, Issue 5, 2014, Pages 371-376

  Unlu, Bekir Serdar ^a   Yildiz, Yunus ^a   Keles, Ibrahim ^b   Kaba, Metin ^a   Kara, Halil ^c   Tasin, Cuma ^a   Erkilinc, Selcuk ^a   Yildirim, Gulcin ^a  

^a Zekai Tahir Burak Mother Health Training and Research Hospital   (Turkey)

^b Yenimahalle State Hospital   (Turkey)

^c YILDIRIM BEYAZIT UNIVERSITY   (Turkey)

Author keywords

Empirical antimicrobial agent; Pregnancy; Urinary tract infection

Indexed keywords

ANTIINFECTIVE AGENT;

ADULT; ARTICLE; ESCHERICHIA COLI; FEMALE; HUMAN; ISOLATION AND PURIFICATION; KLEBSIELLA; METHODOLOGY; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; PREGNANCY; PREGNANCY COMPLICATION; PRENATAL CARE; RETROSPECTIVE STUDY; URINARY TRACT INFECTION; URINE; YOUNG ADULT;

ADULT; ANTI-BACTERIAL AGENTS; ESCHERICHIA COLI; FEMALE; HUMANS; KLEBSIELLA; MICROBIAL SENSITIVITY TESTS; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREGNANCY TRIMESTERS; PRENATAL CARE; RETROSPECTIVE STUDIES; URINARY TRACT INFECTIONS; URINE; YOUNG ADULT;

EID: 84906813965     PISSN: 00170011     EISSN: 25436767     Source Type: Journal    
DOI: 10.17772/gp/1744     Document Type: Article

References (25)

1. McNeeley SG Jr. Treatment of urinary tract infections during pregnancy. Clin Obstet Gynecol. 1988, 3, 480-487.
2. Mittal P, Wing DA. Urinary tract infections in pregnancy. Clin Perinatol. 2005, 32, 749-764.
3. Epoke J, Odigwe CO, Anyanwu GO, [et al.]. The prevalence of significant bacteriuria in diabetic patients in Calabar. Diabet Intern J. 2000, 10, 16-17.
4. Delzell JE Jr, Lefevre ML. Urinary tract infections during pregnancy. Am Fam Physician. 2000, 61, 713-721.
5. Christensen B. Which antibiotics are appropriate for treating bacteriuria in pregnancy? J Antimicrob Chemother. 2000, 46 Suppl 1, 29-34.
6. Kutlay S, Kutlay B, Karaahmetoglu O, [et al.]. Prevalence, detection and treatment of asymptomatic bacteriuria in a Turkish obstetric population. J Reprod Med. 2003, 48, 627-630.
7. Abdullah AA, Al-Moslih MI. Prevalence of asymptomatic bacteriuria in pregnant women in Sharjah, United Arab Emirates. East Mediterr Health J. 2005, 11, 1045-1052.
8. van Brummen HJ, Bruinse HW, van der Bom JG, [et al.]. How do the prevalences of urogenital symptoms change during pregnancy? Neurourol Urodyn. 2006, 25, 135-139.
9. Amiri FN, Rooshan MH, Ahmady MH, Soliamari MJ. Hygiene practices and sexual activity associated with urinary tract infection in pregnant women. East Mediterr Health J. 2009, 15, 104-110.
10. Mincey BA, Parkulo MA. Antibiotic prescribing practices in a teaching clinic: comparison of resident and staff physicians. South Med J. 2001, 94, 365-369.
11. Hill JB, Sheffield JS, McIntire DD, Wendel GD. Acute pyelonephritis in pregnancy. Obstet Gynecol. 2005, 105, 18-23.
12. Alemu A, Moges F, Shiferaw Y, [et al.]. Bacterial profile and drug susceptibility pattern of urinary tract infection in pregnant women at University of Gondar Teaching Hospital, Northwest Ethiopia. BMC Res Notes. 2012, 5, 197.
13. Lumbiganon P, Laopaiboon M, Thinkhamrop J. Screening and treating asymptomatic bacteriuria in pregnancy. Curr Opin Obstet Gynecol. 2010, 22, 95-99.
14. Celen S, Oruç AS, Karayalçin R, [et al.]. Asymptomatic bacteriuria and antibacterial susceptibility patterns in an obstetric population. ISRN Obstet Gynecol. 2011, doi: 10.5402/2011/721872
15. Smaill F, Vazquez JC. Antibiotics for asymptomatic bacteriuria in pregnancy. Cochrane Database Syst Rev. 2007, CD000490.
16. Patterson TF, Andriole VT. Detection, significance, and therapy of bacteriuria in pregnancy. Update in the managed health care era. Infect Dis Clin North Am. 1997, 11, 593-608.
17. Lang JM, Lieberman E, Cohen A. A comparison of risk factors for preterm labor and term smallfor-gestational-age birth. Epidemiology. 1996, 7, 369-376.
18. Millar LK, DeBuque L, Wing DA. Uterine contraction frequency during treatment of pyelonephritis in pregnancy and subsequent risk of preterm birth. J Perinat Med. 2003, 31, 41-46.
19. Cox SM, Shelburne P, Mason R, [et al.]. Mechanisms of hemolysis and anemia associated with acute antepartum pyelonephritis. Am J Obstet Gynecol. 1991;164:587-590.
20. Artero A, Alberola J, Eiros JM, [et al.]. Pyelonephritis in pregnancy. How adequate is empirical treatment? Rev Esp Quimioter. 2013, 26, 30-33.
21. Meier S, Weber R, Zbinden R, [et al.]. Extended-spectrum beta-lactamase-producing Gramnegative pathogens in community-acquired urinary tract infections: an increasing challenge for antimicrobial therapy. Infection. 2011, 39, 333-340.
22. Pitout JD, Laupland KB. Extended-spectrum beta-lactamase-producing Enterobacteriaceae: an emerging public-health concern. Lancet Infect Dis. 2008, 8, 159-166.
23. Zahar JR, Lortholary O, Martin C, [et al.]. Addressing the challenge of extended-spectrum betalactamases. Curr Opin Investig Drugs. 2009, 10, 172-180.
24. Kazemier BM, Schneeberger C, De Miranda E, [et al.]. Costs and effects of screening and treating low risk women with a singleton pregnancy for asymptomatic bacteriuria, the ASB study. BMC Pregnancy Childbirth. 2012, 12, 52.
25. Enayat K, Fariba F, Bahram N. Asymptomatic bacteriuria among pregnant women referred to outpatient clinics in Sanandaj, Iran. Int Braz J Urol. 2008, 34, 699-704.